HAEMOPHILIA A
Clinical trials for HAEMOPHILIA A explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial aims to stop dangerous bleeds in untreated hemophilia patients
Disease control Recruiting nowThis study is testing the safety and effectiveness of a drug called SCT800 to prevent bleeding episodes in people with severe hemophilia A. It will involve 36 male patients who have never received standard clotting factor treatment before. The main goal is to see if the drug work…
Matched conditions: HAEMOPHILIA A
Phase: PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Oral hemophilia treatment enters human testing
Disease control Recruiting nowThis early study is testing a new oral medicine called Inno8 in people with Hemophilia A to see if it's safe and how the body processes it. About 30 adult men with Hemophilia A will take different doses of the medicine over 11 weeks. Researchers will monitor for side effects and …
Matched conditions: HAEMOPHILIA A
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Tracking new hemophilia treatments in children and First-Time patients
Disease control Recruiting nowThis study follows 200 patients with severe hemophilia A who are just starting treatment with one of three specific clotting factor products. Researchers will observe how well these treatments control bleeding in real-world settings and monitor for safety issues, particularly foc…
Matched conditions: HAEMOPHILIA A
Sponsor: Octapharma • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
First tests begin on potential new bleeding disorder drug
Knowledge-focused Recruiting nowThis is a first-in-human study to check if a new medicine called Inno8 is safe and how it behaves in the body. It will involve 108 healthy male volunteers who will receive the drug or a placebo via injection or pill. The main goal is to gather safety information to support future…
Matched conditions: HAEMOPHILIA A
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Looking back at bleeding disorder care in iraq
Knowledge-focused Recruiting nowThis study aims to understand how a specific medicine for Hemophilia A is used in everyday practice in Iraq. Researchers will look back at the medical records of about 900 male patients, both children and adults, who have switched to this treatment. The goal is to collect informa…
Matched conditions: HAEMOPHILIA A
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
Scientists test if breakfast timing boosts new bleeding disorder drug
Knowledge-focused Recruiting nowThis study aims to understand how eating before and after taking a new oral medicine called Inno8 affects how the body absorbs it. It will involve 80 healthy male volunteers who will take a single dose under different fasting conditions. The main goal is to gather data to help de…
Matched conditions: HAEMOPHILIA A
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC